John Hayslip, M.D. (’01), has been named chief medical officer for Verastem Oncology. The Boston-based company specializes in advancing new medicines for patients with cancer.
"John is a recognized leader in oncology with broad expertise across cancer research and development, business development and organizational leadership, and we welcome him to the Verastem team," said Dan Paterson, president and CEO of Verastem Oncology, in an announcement of Dr. Hayslip’s appointment. "John’s extensive experience will be integral as we advance our clinical programs focused on RAS/MAPK pathway-driven cancers."
Dr. Hayslip is a 2001 graduate of the College of Medicine. He completed residency at Summa Health prior to a fellowship in hematology and medical oncology at the University of South Carolina.
Read the full article in Yahoo! Finance.